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Background: Sleep abnormalities are increasingly recognised to 
emerge early in dementia, at or before the Mild Cognitive Impairment 
(MCI) phase.  Abnormal sleep accelerates cognitive decline and may 
directly contribute to pathophysiology.  Its accurate measurement is 
therefore crucial, firstly to characterise sleep abnormalities in early 
disease potentially facilitating earlier identification of those at risk of 
dementia and secondly to test sleep intervention efficacy.  However, it 
is our a priori hypothesis that sleep outcomes are reported 
heterogeneously inhibiting side-by-side comparison of study findings.  
As a translational step towards informing choice and decisions on 
optimal measures, this scoping review will describe measurement 
tools utilised and sleep parameters currently reported in early 
dementia and MCI.  
Methods: This scoping review follows the Joanna Briggs Institute 
Manual for Evidence Synthesis for Scoping Reviews.  The search 
strategy consists of an electronic search of the CINAHL Plus, Embase, 
Medline, Psychinfo and British Nursing Index databases and date 
limited to articles published from 2000.  Search results will be merged 
using reference management software and duplicates removed.  10% 
of returned titles and abstracts will be checked by each reviewing 
member to ensure continuity of decision making.  Full-texts will be 
reviewed by at least two reviewers with discrepancies resolved by 
whole team consensus.  A PRISMA flow diagram will document the 
selection process.  Extracted data will be analysed and reported 
narratively.  
Discussion: This scoping review will identify which sleep parameters 
are reported and the means by which they are measured in people 
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with MCI or early dementia.  We intend to explore differences in 
reporting practice within group subsets, e.g. by dementia and study 
subtype.    
Ethics and dissemination: Ethical approval is not required due to 
absence of human participants.  Results will be published in a peer-
reviewed journal and presented at relevant academic conferences.  
The search strategy will be made available publicly for transparency.
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Introduction
Sleep abnormalities and circadian rhythm disturbance are 
well recognised in established dementia1–5. These include 
objectively measured micro and macro-architectural disturbances 
of sleep, alongside subjective reports of reduced quantity and 
quality2, all of which are disproportionately represented 
compared with age-matched controls and correlate closely with 
the severity of cognitive impairment6,7. Circadian rhythm dis-
orders, contributing to sleep disturbance are also generally 
more marked in dementia than in healthy ageing – possibly 
related to volumetric alterations in the Suprachiasmatic Nucleus 
influencing melatonin secretion8. 
As opposed to solely representing a marker of established 
disease, sleep abnormalities are increasingly recognised to occur 
much earlier in the natural history of dementia, during and 
even preceding the Mild Cognitive Impairment (MCI) stage9,10. 
Furthermore, conditions with sleep abnormalities but nor-
mal cognition e.g. chronic insomnia, increase future risk of 
Alzheimer’s Disease (AD) dementia11,12. In Lewy body dementia, 
sleep disturbances also precede disease onset. Rapid eye move-
ment-sleep behaviour disorder can present several years before 
disease manifestation and predict cognitive impairment13.
Whilst such abnormalities in sleep may reflect early symp-
tomatic manifestation of pathology, there are also plausible 
mechanisms by which sleep abnormalities could precipitate or 
accelerate pathophysiological decline14–18. In AD, sleep abnor-
malities have been hypothesised to contribute to diminished 
clearance of a key pathognomonic feature - beta-amyloid17,18, 
supported by work showing the unique role of Slow Wave Sleep 
(SWS) in removing intracerebral toxic breakdown products 
(including beta amyloid) in mice19. Supporting this, SWS dis-
ruption in both healthy adults and those with AD is associated 
with greater levels of beta-amyloid pathology20.
The pathological changes associated with multiple subtypes 
of dementia predate symptomatic expression of symptoms by 
decades21,22 and as such a promising future strategy will be 
targeting early stages of the disease when pathology is more 
likely to be reversible and quality of life can be retained. Given 
that sleep abnormalities arise early, they may provide an ideal 
means to identify those at highest risk of dementia and this early 
identification is potentially crucial when implementing thera-
peutic modalities to alter the pathological disease course in the 
future. In addition, optimising sleep itself is hypothesised as 
an opportunity to delay progression of neurodegenerative dis-
ease whilst simultaneously promoting physiological processes 
that improve cognition (particularly long-term memory con-
solidation), general health and wellbeing. As a result, there is 
much current interest in enhancing understanding of the pre-
cise nature of sleep abnormalities in dementia, their presence 
prior to onset of clinical symptoms and trials of interventions to 
improve sleep disturbances.
However, whilst providing a rich vein of opportunity for 
deeper characterisation and intervention, sleep is a challenging 
concept to measure in dementia - both due to its complex 
nature and the target population. As a multidimensional con-
cept, sleep is measurable across levels and aspects23,24. For 
example, levels of measurement may include self-report ques-
tionnaires, behavioural measures, e.g. actigraphy, physiologi-
cal means, e.g. polysomnography, and less commonly analyses 
at the circuit or cellular level. For the purposes of this review 
these will be referred to as measurement tools. Within each 
level, multiple aspects may be recorded e.g. sleep duration, 
efficiency etc., which for the purpose of this review will be 
referred to as sleep parameters. Furthermore, measuring sleep in 
MCI and early dementia is unique as it encompasses challenges 
not seen in healthy populations25, whilst also allowing for a 
wider range of techniques when compared to those in later stage 
disease. 
It is our a priori hypothesis that these factors ally to potentially 
compromise comparison and reproducibility of work designed 
to facilitate detailed characterisation of sleep and also to 
assess the effects of interventions. A recent systematic review 
reporting objective sleep measurement findings in MCI 
was unable to render specific conclusions relating to micro- 
architectural sleep as no two studies were found to report the 
same parameters10. Similarly a systematic review exploring 
sleep interventions in MCI was confined to narrative review 
due to outcome measure heterogeneity26.
There is a pressing need to develop a recommended outcome 
set of sleep parameters and the optimal means by which they 
can be measured. As a translational step towards this, a scop-
ing review was considered the most appropriate framework in 
exploring current research conduct within the field. To our 
knowledge, to date, no reviews exist describing current prac-
tices in measuring and reporting sleep within this population in 
clinical settings, or in interventional and observational stud-
ies, supported by an absence of systematic reviews or scop-
ing reviews found through preliminary searches of MEDLINE, 
EMBASE and PROSPERO. 
The primary objective of this scoping review therefore aims 
to address this gap in the literature by exploring which sleep 
outcome variables are reported and the means by which they 
are measured in the current literature. Secondarily it aims to 
describe how this differs in interventional vs. observational 




“How is sleep currently measured and reported in the litera-
ture from studies involving participants with Mild Cognitive 




1.  Adults aged greater than 18 (limit set to avoid 
excluding studies in genetic dementias); and
2.  Male or Female; and
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3.  a) Satisfies established diagnostic criteria for MCI or 
minor neurocognitive disorder e.g. Albert Criteria, 
Peterson Criteria, DSM V.
  b) Satisfies established diagnostic criteria for demen-
tia or major neurocognitive disorder e.g. DSM-IV, 
ICD-10, ICD-11, NINCDSARDA, DSM-V.
4.  The majority (≥50%) of the study group has 
mild/early dementia/MCI as evidenced by:
a)     MMSE ≥ 20
b)     CDR < 2
c)     Equivalent measure
Concept
All included studies will meet the following two criteria:
1.  Sleep measurement/assessment is a key component 
of interest as evidenced by one or more objective 
relating to sleep defined within the original aims and 
objectives of the study. 
  AND
2.  Sleep outcomes/parameters e.g. total sleep time, sleep 
efficiency, subjective experience of sleep are reported 
through use of a sleep outcome measure/tools which 
demonstrate efficacy and have been validated. 
Context. This review aims to capture studies conducted in 
community and health-care settings.
Types of evidence sources. This scoping review will consider 
published, peer-reviewed articles written in English. Specifically, 
those reporting both experimental and quasi-experimental study 
designs including randomised controlled trials, before and 
after studies and interrupted time-series studies. In addition, 
analytical observational studies including prospective and ret-
rospective cohort studies, case-control studies and analyti-
cal cross-sectional studies as well as descriptive observational 
study designs including case series, individual case reports and 
descriptive cross-sectional studies will be considered for inclu-
sion alongside qualitative studies. Review papers, text and 
opinion papers are ineligible. 
This proposed scoping review will be conducted in accord-
ance with the Joanna Briggs Institute (JBI) methodology for 
scoping reviews27. 
Search strategy
An initial search of MEDLINE and EMBASE via Ovid was 
undertaken to identify relevant articles utilising an initial search 
strategy (see Box 1). The text words contained in titles and 
abstracts of a selection of relevant articles will be used to 
inform the full search strategy. The search strategy, including 
all identified keywords and index terms will be adapted for each 
included database. 
Box 1. Preliminary search strategy 
1.      (Sleep* or slept or insomni*).ab. or (Sleep* or slept or 
insomni*).ti.
2.      Sleep/ or exp insomnia/
3.      1 or 2
4.      (MCI or MNCD or AAMI or AACD or MCD or ARCD or NMCI 
or AMCI or MMCI or SMCI or MCIA or LBD or FTLD or FTD).
ti,ab.
5.      exp Dementia/
6.      (dement* or alzheim* or lewy or frontotemporal).ti,ab.
7.      ((Cognit* or Neurocognit* or Neurodegenerat*) adj3 
(disorder* or impair* or declin* or dement* or deficit* or 
dysfunction* or disease* or impair*)).ti,ab.
8.      4 or 5 or 6 or 7
9.      3 and 8
10.    exp animals/ not exp humans/
11.    9 not 10
12.    11
13.    limit 12 to english language
14.    (measur* or assess* or question* or evaluat* or quanti* 
or apprais* or guage* or guaging or test* or examin* or 
inventor* or survey*).ti,ab.
15.    9 and 14
16.    15 not 10
17.    16
18.    limit 17 to english language
19.    limit 18 to articles published after 1999
Due to the substantial number of included articles antici-
pated, reference searching within included articles will not be 
performed. In order to ensure that this review reflects contem-
poraneous practice, the search will be limited to articles pub-
lished after 1999, at which point objective measurement of sleep 
became more routinely available. 
An electronic search of the CINAHL Plus, Embase, Medline, 
PsychInfo and British Nursing Index databases will be 
performed.
Selection of eligible studies
Following the search, all identified citations will be col-
lated and uploaded into reference management software with 
duplicates removed. Titles of studies clearly unrelated to the 
participants and concept of the scoping review will also be 
removed. Two reviewers will independently review 10% of the 
remaining abstracts against the inclusion criteria as stated. 
They will meet to compare their selection of articles. If agree-
ment is above 90% between the two reviewers for at least 
10% of the papers, one reviewer will review the remaining 
abstracts. If agreement does not reach that level, then a further 
10% will be reviewed by the two reviewers and further discus-
sion held. This process will be repeated until there is less than 
10% disagreement. Once all abstracts have been reviewed, 
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potentially relevant sources for full text review will then be 
retrieved in full and their citation details imported into JBI 
system for the Unified Management, Assessment and Review 
of Information (SUMARI)28. The two reviewers will review 
all papers independently at full text level with regular consen-
sus meetings. Reasons for the exclusion of sources at full text 
will be recorded and reported in the scoping review. Any dis-
agreements that arise between the reviewers at each stage 
of the selection process will be resolved through either 
discussion or with an additional reviewer/s. The selection 
process will be reported in full within the final scoping review 
and presented in a Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses extension for scoping review 
(PRISMA-ScR) flow diagram29. 
Data extraction
Data will be extracted from papers included in the scop-
ing review by a member of the reviewing team utilising a data 
extraction tool developed by the reviewers (see Table 1). The 
data extracted will include details of the participants, study 
Table 1. Data extraction form. Adapted from27.
Scoping review details
Scoping Review Title Measurement of Sleep in Mild Cognitive Impairment and Early Dementia: A Scoping Review
Review Question “How is sleep currently measured and reported in studies involving participants with Mild Cognitive Impairment (MCI) and early dementia?”
Inclusion/exclusion criteria
Population
1. Adults > 18 
2. Male or Female 
3. Satisfies diagnostic criteria for Mild Cognitive Impairment or Dementia 
4. Majority of group has mild cognitive symptoms as evidenced by: 
    a. MMSE ≥ 20 
    b. CDR < 2 
    c. Equivalent Measure
Concept
1. Sleep measurement / assessment defined within aims and objectives of the study.  
2. Validated sleep outcome measure / tool 
Context Community and health-care settings
Types of Evidence Source
1. Written in English Language 
2. Peer Reviewed Published Articles 
3. Interventional, observational or qualitative studies





Context Community Healthcare 
Participant Number
Participant Gender (Female)
Participant MMSE / CDR / Other
Participant Diagnosis (%) Mild Cognitive Impairment Dementia 
Type of Dementia(s) (%)
Type Of Study
Interventional / Observational Interventional Observational
Details/results extracted from evidence source
Validated Outcome Measures
Sleep Parameters Reported
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Table 2. Individual study characteristics.
Table Heading Description
Author / Year Author and year study published
Interventional / Observational Study Interventional or Observational Design
Study Design Type of Study e.g. RCT / Cohort / Case-Control
Study Population Number of Participants
Population Diagnosis Diagnosis of Participants e.g. MCI / Early AD
Outcome Measure(s) Reported Sleep Parameter(s) reported
Sleep Measurement Tool(s) Utilised Validated sleep tool(s) utilised
methods, concept, context and key findings regarding outcome 
measures pertinent to the review question. Any modifica-
tions required during the process of data extraction will be 
detailed within the full scoping review. Attempts will be made 
to contact authors to resolve issues relating to missing, unclear 
or incomplete data. This review is designed to highlight sleep 
outcomes reported in the literature rather than evaluate study 
quality, as such critical appraisal and risk of bias analysis 
will not be undertaken. 
Data analysis and presentation
Attributes of each included study will be listed (headings 
described in Table 2). 
A balloon plot will be produced combining sleep out-
come parameters on one axis with validated sleep tool on 
the other axis (see Figure 1 for example). Two further bal-
loon plots will be produced. Each will stratify the group 
Figure 1. Balloon plot of frequency of reported parameters by sleep measure (example).
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Figure 2. Stratified balloon plot template – sleep parameters.
by participant diagnosis and also by study type. These 
will plot the proportion of studies reporting each sleep 
parameter (see Figure 2) and the proportion of studies 
utilising each sleep measurement tool (see Figure 3). This 
will be followed by a narrative summary of collected 
data. 
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The results of this review will provide an understanding as to 
ways and means by which sleep is measured in this specific 
group allowing for identification of the tools and parameters 
most likely to facilitate comparison across studies. 
Study status
Full search is currently pending.
Dissemination
Results will be published in a peer-reviewed journal and 
presented at relevant academic conferences. The search 
strategy will be made available publicly for transparency. 
Data availability
No data are associated with this article
Figure 3. Stratified balloon plot template – measurement tools.
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